Lehr Martin A.
Known title: Chief Executive OfficerCIK: 0001861989
Lehr Martin A.'s purchase track record
How the stock did after each of Lehr Martin A.'s open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
9
of 9 since October 22, 2021
Stock higher 6 months later
67%
3 months: 11%
Median 6-month return
+40.3%
3 months: -16.5%
Beat the S&P 500
67%
median +31.8% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 6/9/2025 | CNTX | $70K | +16.8% | +50.8% | +14.0% |
| 2/21/2023 | CNTX | $5K | -13.1% | +32.0% | +9.8% |
| 2/13/2023 | CNTX | $5K | -41.4% | +40.3% | +8.5% |
| 1/30/2023 | CNTX | $10K | -16.5% | +61.1% | +14.2% |
| 1/17/2023 | CNTX | $10K | -6.8% | +78.7% | +14.1% |
| 12/16/2022 | CNTX | $15K | -16.4% | +74.3% | +14.5% |
| 8/19/2022 | CNTX | $24K | -32.2% | -54.8% | -3.5% |
| 12/16/2021 | CNTX | $42K | -42.0% | -36.4% | -21.5% |
| 10/22/2021 | CNTX | $50K | -70.0% | -76.8% | -6.0% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| CNTX | ▲ Buy | Open Market | 100,000 | $70K | 6/9/2025 | View on chart |
| CNTX | ▲ Buy | Open Market | 5,823 | $5K | 2/21/2023 | View on chart |
| CNTX | ▲ Buy | Open Market | 5,606 | $5K | 2/13/2023 | View on chart |
| CNTX | ▲ Buy | Open Market | 5,040 | $5K | 2/6/2023 | View on chart |
| CNTX | ▲ Buy | Open Market | 7,027 | $5K | 1/30/2023 | View on chart |
| CNTX | ▲ Buy | Open Market | 6,839 | $5K | 1/23/2023 | View on chart |
| CNTX | ▲ Buy | Open Market | 6,783 | $5K | 1/17/2023 | View on chart |
| CNTX | ▲ Buy | Open Market | 20,000 | $15K | 12/16/2022 | View on chart |
| CNTX | ▲ Buy | Open Market | 13,000 | $24K | 8/19/2022 | View on chart |
| CNTX | ▲ Buy | Open Market | 13,000 | $42K | 12/16/2021 | View on chart |
| CNTX | ▲ Buy | Open Market | 10,000 | $50K | 10/22/2021 | View on chart |
| CNTX | ▼ Sell | Other | 52,680 | $376K | 10/22/2021 | View on chart |
| CNTX | ▼ Sell | Other | 210,722 | — | 10/22/2021 | View on chart |
| CNTX | ▼ Sell | Other | 586,476 | — | 10/22/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 15, 2026
CNTX appears on Yahoo's recent strong negative rating lists
Yahoo listed Context Therapeutics in its strong negative rating lists for October 13 and October 15. The inclusion reflects recent analyst concerns about the company's outlook. The stock is currently trading with a low RSI and near its identified support level, which aligns with the negative sentiment.
CNTX appears on Yahoo's recent strong negative rating lists. Yahoo listed Context Therapeutics in its strong negative rating lists for October 13 and October 15. The inclusion reflects recent analyst concerns about the company's outlook. The stock is currently trading with a low RSI and near its identified support level, which aligns with the negative sentiment.